Aziyo Biologics Inc. (AZYO)

AI Score

Unlock

1.49

0.03 (2.05%)

At close: Sep 06, 2023, 7:59 PM

Aziyo Biologics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019
Net Income	-312K	-10.62M	-7.97M	-5.44M	-9.91M	-9.4M	-8.15M	-9.06M	-8.32M	-2.38M	-5.07M	-5.36M	-6.73M	-5.18M	-4.56M	-2.78M	-3.1M
Depreciation & Amortization	n/a	954K	947K	937K	933K	934K	929K	933K	932K	932K	933K	943K	972K	975K	974K	970K	967K
Stock-Based Compensation	n/a	687K	684K	774K	298K	1.47M	1.1M	973K	1M	885K	677K	595K	58K	72K	54K	52K	49K
Other Working Capital	n/a	144K	1.43M	-2.91M	3.16M	136K	68K	273K	-145K	1.23M	-713K	-1.85M	1.74M	122K	185K	330K	485K
Other Non-Cash Items	312K	2.86M	849K	-3.98M	1.01M	673K	675K	697K	692K	-2.34M	693K	701K	4.13M	702K	694K	-1.13M	747K
Deferred Income Tax	n/a	834K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-3.03M	n/a	227K	2.34M	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	2.9M	328K	2.47M	2.15M	3M	-1.91M	74K	2.59M	2.12M	-2.41M	-2.25M	346K	-562K	-200K	314K	-1.06M
Operating Cash Flow	-312K	-2.39M	-5.17M	-5.25M	-5.51M	-3.32M	-7.35M	-6.39M	-3.1M	-787K	-5.17M	-5.37M	-1.23M	-3.99M	-3.04M	-2.57M	-2.4M
Capital Expenditures	n/a	-85K	-182K	-134K	-117K	-255K	-34K	-25K	-97K	-116K	-131K	-115K	-436K	-27K	-62K	-155K	-163K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	-85K	-182K	-134K	-117K	-255K	-34K	-25K	-97K	-116K	-131K	-115K	-436K	-27K	-62K	-155K	-163K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	-19K	148K	14.27M	-2.78M	-2.08M	-869K	14.21M	-2.55M	-1.23M	-3.73M	43.37M	2.27M	4.43M	1.14M	4.74M	2.54M
Financial Cash Flow	n/a	-19K	148K	14.27M	-2.78M	-2.08M	-869K	14.21M	-2.55M	-1.23M	-3.73M	43.37M	2.27M	4.43M	1.14M	4.74M	2.54M
Net Cash Flow	-312K	-2.49M	-5.2M	8.89M	-8.41M	-5.66M	-8.25M	7.8M	-5.74M	-2.13M	-9.03M	37.89M	604K	414K	-1.96M	2.01M	-20K
Free Cash Flow	-312K	-2.47M	-5.35M	-5.38M	-5.63M	-3.58M	-7.38M	-6.41M	-3.19M	-903K	-5.3M	-5.48M	-1.67M	-4.02M	-3.1M	-2.73M	-2.56M